Lifesome Therapeutics

Lifesome Therapeutics is a nanotechnology start-up dedicated to synthesizing and formulating a new generation of drug delivery systems. Its technology is based on a single lipid component, characterized by two distinctive properties:

• it is an alkyl-ether-glycerolipid with intrinsic therapeutic properties, that is: it acts as an active therapeutic agent;
• its simple synthesis allows for formulating various structural conformations, such as nanotubes, nanoparticles, hydrogels, or nanomaterial for 3D printing.

These particularities provide new advantages compared to current drug delivery therapies, as they enable the active encapsulation of any substance of therapeutic interest in desired concentrations, adapting to any mode of administration. Additionally, being an active agent, it enhances the effect of the encapsulated therapeutic molecules, resulting in beneficial synergies.

The technology, patented and supported by various scientific studies, demonstrates its exceptional potential for use in advanced therapies against cancer and bacterial infections. Work is currently underway to extend its scope to other therapeutic areas related to aging and diagnosis, such as theranostics.

At Lifesome, we not only offer this new technology, but we also provide technical support and full collaboration to public and private research projects.